On Sep. 28, SEC fined Stryker medical $7.8mn FCPA violations.
- For second time Stryker medical device has been charged with FCPA failures.
- Company violated books, records and internal accounting controls provisions.
- Internal accounting controls did not detect risk of improper payment in sales
in India, Chin, and Kuwait, and Indian subsidiary did not keep proper records.